Public Finance Perspective from Recent Studies on Finnish Pharmaceutical Markets

Antto Jokelainen, Jaakko Markkanen, Markku Siikanen and Otto Toivanen

No 157, ETLA Brief from The Research Institute of the Finnish Economy

Abstract: Abstract Petteri Orpo’s government program plans to reform pharmaceutical and pharmacy regulation in Finland. In this memo, we review some of the effects of cost-saving measures targeted at the pharmaceutical markets in light of recent economic research. We present two recommendations. First, we propose transferring medicines to the general VAT rate. Secondly, we recommend reforming or replacing the pharmacy tax with the standard corporate tax, should the regulation of pharmacy numbers and locations be removed.

Keywords: Pharmaceuticals; Pharmacies; Regulation; Public finance (search for similar items in EconPapers)
JEL-codes: C23 H51 I11 L43 L51 L81 R12 (search for similar items in EconPapers)
Pages: 10 pages
Date: 2025-04-17
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.etla.fi/wp-content/uploads/ETLA-Muistio-Brief-157.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:rif:briefs:157

Ordering information: This working paper can be ordered from
https://www.etla.fi/ ... -kokonaisuudistusta/

Access Statistics for this paper

More papers in ETLA Brief from The Research Institute of the Finnish Economy Contact information at EDIRC.
Bibliographic data for series maintained by Kaija Hyvönen-Rajecki ().